Literature DB >> 1337420

"Reducing body"-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency.

V Jay1, J Christodoulou, A Mercer-Connolly, R R McInnes.   

Abstract

Unusual inclusions with some of the features of "reducing bodies" were encountered in the skeletal muscle biopsy of a 2.5-year-old boy with childhood-onset acid maltase deficiency. The biopsy revealed a vacuolar myopathy with lysosomal storage of glycogen and eosinophilic refractile inclusions in myofibers, which appeared dark blue with the menadione-nitroblue tetrazolium reaction. The significance of the association of inclusions with reducing properties in the setting of acid maltase deficiency is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337420     DOI: 10.1007/bf00304641

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Department of Neurology, Northwestern University Medical School, Chicago, Illinois.

Authors:  V Sahgal; S Sahgal
Journal:  Acta Neuropathol       Date:  1977-03-31       Impact factor: 17.088

2.  Congenital myopathy with "reducing bodies" in muscle fibres.

Authors:  F M Tomé; M Fardeau
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

3.  Reducing body myopathy.

Authors:  M H Brooke; H E Neville
Journal:  Neurology       Date:  1972-08       Impact factor: 9.910

4.  A benign form of reducing body myopathy.

Authors:  S J Oh; G J Meyers; E R Wilson; C B Alexander
Journal:  Muscle Nerve       Date:  1983-05       Impact factor: 3.217

5.  Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.

Authors:  A J Reuser; M Kroos; R Willemsen; D Swallow; J M Tager; H Galjaard
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  [Granular body myopathy (so-called reducing body myopathy)].

Authors:  G Hübner; D Pongratz
Journal:  Pathologe       Date:  1982-03       Impact factor: 1.011

7.  New observations in reducing body myopathy.

Authors:  S Carpenter; G Karpati; P Holland
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

8.  [Reducing body myopathy--ultrastructure and classification (author's transl)].

Authors:  G Hübner; D Pongratz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981
  8 in total
  5 in total

Review 1.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

2.  Reducing bodies in distal myopathy with rimmed vacuole formation.

Authors:  B H Kiyomoto; N Murakami; J Kishibayashi; N Sunohara; I Nonaka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.

Authors:  Erin J Feeney; Stephanie Austin; Yin-Hsiu Chien; Hanna Mandel; Benedikt Schoser; Sean Prater; Wuh-Liang Hwu; Evelyn Ralston; Priya S Kishnani; Nina Raben
Journal:  Acta Neuropathol Commun       Date:  2014-01-02       Impact factor: 7.801

4.  Familial adult-onset Pompe disease associated with unusual clinical and histological features.

Authors:  Lorenzo Maggi; Franco Salerno; Cinzia Bragato; Simona Saredi; Flavia Blasevich; Elio Maccagnano; Barbara Pasanisi; Cesare Danesino; Marina Mora; Lucia Morandi
Journal:  Acta Myol       Date:  2013-10

Review 5.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.